Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Raul Armando Luyo Saboya
Observed name:
Raul Saboya
Institution:
Ospedale San Bortolo
Observed institution:
Ospedale San Bortolo
ORCID:
0009-0004-7290-0515
Observed ORCID:
0009-0004-7290-0515
OpenAlex ID:
A5133622177
Efficacy of abrocitinib and baricitinib on ‘difficult-to-treat areas’ in patients with atopic dermatitis: a multicentre study
2024
·
Maddalena Napolitano
, Luca Potestio
, et al.
·
Clinical and Experimental Dermatology
·
6
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)
2026
·
Elena Pezzolo
, Rossi Mariateresa
, et al.
·
Acta Dermato Venereologica
·
1
Upadacitinib for the Management of Atopic Dermatitis in Patients Aged ≥60 Years: A Long-Term Multicenter Real-World Study
2026
·
Elena Ippoliti
, Niccolò Gori
, et al.
·
Dermatitis
Cumulative Disease Control with Upadacitinib in Moderate-to-Severe Atopic Dermatitis—A 52-Week Multicenter Real-World Study: IL-AD (Italian Landscape Atopic Dermatitis)
2026
·
Luca Potestio
, Matteo Bianco
, et al.
·
Dermatology and Therapy
PDF
Efficacy and Safety of Delgocitinib and Its Impact on Patient’s Perspective for Moderate-to-severe Chronic Hand Eczema in Adults: A 16-week Real-world Prospective Multicentre Study
2026
·
Elena Pezzolo
, Raul Armando Luyo Saboya
, et al.
·
Acta Dermato Venereologica
PDF
Real-life effectiveness and safety of lebrikizumab in older patients with atopic dermatitis: a multicentre study
2026
·
Maddalena Napolitano
, Giuseppe Lauletta
, et al.
·
Clinical and Experimental Dermatology
Show more works
View as search
Works count:
6
Citation count:
7
H-index:
1
I10-index:
Year
Topic
Type
